RAMBO MEDICAL GROUP, INC.
CIK:0001350421|SEC Filings
Condensed Statements of Operations (unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Nov. 30, 2018 |
Nov. 30, 2017 |
Nov. 30, 2018 |
Nov. 30, 2017 |
|
| Operating Expenses | ||||
| General and administrative | $ 11,175 | $ 5,273 | $ 19,405 | $ 13,873 |
| Total operating expenses | 11,175 | 5,273 | 19,405 | 13,873 |
| Loss from operations | (11,175) | (5,273) | (19,405) | (13,873) |
| Net Income (Loss) | $ (11,175) | $ (5,273) | $ (19,405) | $ (13,873) |
| Basic and diluted loss per common share: | $ (0.011) | $ (0.005) | $ (0.020) | $ (0.010) |
| Weighted average number of shares outstanding | 992,192 | 992,192 | 992,192 | 992,192 |
Condensed Statements of Cash Flows (unaudited) - USD ($) |
6 Months Ended | |
|---|---|---|
Nov. 30, 2018 |
Nov. 30, 2017 |
|
| Operating Activities | ||
| Net Income (Loss) | $ (19,405) | $ (13,873) |
| Changes to operating assets and liabilities: | ||
| Accounts payable | (195) | 6,321 |
| Due to related party | 20,000 | 0 |
| Accrued interest | 0 | 0 |
| Net cash provided by (used in) operating activities | 400 | (7,552) |
| Net increase (decrease) in cash | 400 | (7,552) |
| Cash at the beginning of period | 6,700 | 8,611 |
| Cash at the end of period | 7,100 | 1,058 |
| Supplemental Cash Flow Information | ||
| Interest Paid, Including Capitalized Interest, Operating and Investing Activities | 0 | 0 |
| Income Taxes Paid, Net | $ 0 | $ 0 |
Condensed Balance Sheet (unaudited) - USD ($) |
Nov. 30, 2018 |
May 31, 2018 |
|---|---|---|
| Current assets | ||
| Cash | $ 7,100 | $ 6,700 |
| Total assets (all current) | 7,100 | 6,700 |
| Current liabilities | ||
| Accounts payable | 7,491 | 7,686 |
| Due to related party | 43,859 | 43,859 |
| Total liabilities (all current) | 51,350 | 51,545 |
| Non-Current Liabilities | ||
| Due to related party, net of current portion | 205,000 | 185,000 |
| Total liabilities | 256,350 | 236,545 |
| Stockholders' deficit | ||
| Common Stock, Value, Issued | 991 | 991 |
| Additional paid-in capital | 7,043,222 | 7,043,222 |
| Accumulated deficit | (7,293,463) | (7,274,058) |
| Total stockholders' deficit | (249,251) | (229,846) |
| Total liabilities and stockholders' deficit | $ 7,100 | $ 6,700 |